Differential Regulation of Amyloid-β Endocytic Trafficking and Lysosomal Degradation by Apolipoprotein E Isoforms*♦
暂无分享,去创建一个
Jie Li | Huaxi Xu | G. Bu | M. LaDu | T. Kanekiyo | M. Shinohara | Yunwu Zhang
[1] Thomas W. Mühleisen,et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease , 2013, Nature Genetics.
[2] L. Mucke,et al. Alzheimer Mechanisms and Therapeutic Strategies , 2012, Cell.
[3] D. Holtzman,et al. Low-density Lipoprotein Receptor Represents an Apolipoprotein E-independent Pathway of Aβ Uptake and Degradation by Astrocytes* , 2012, The Journal of Biological Chemistry.
[4] Guojun Bu,et al. Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.
[5] B. Strooper,et al. The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes , 2012, Nature Neuroscience.
[6] A. Fagan,et al. Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance , 2011, Science Translational Medicine.
[7] D. G. Clark,et al. Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease , 2011, Nature Genetics.
[8] G. Bu,et al. Heparan Sulphate Proteoglycan and the Low-Density Lipoprotein Receptor-Related Protein 1 Constitute Major Pathways for Neuronal Amyloid-β Uptake , 2011, The Journal of Neuroscience.
[9] R. Bateman,et al. Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease , 2010, Science.
[10] G. Bu,et al. Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Mediates Neuronal Aβ42 Uptake and Lysosomal Trafficking , 2010, PloS one.
[11] Du Feng,et al. Membrane localization of beta-amyloid 1-42 in lysosomes: a possible mechanism for lysosome labilization. , 2010, The Journal of biological chemistry.
[12] D. Westaway,et al. Lysosomal Proteolysis and Autophagy Require Presenilin 1 and Are Disrupted by Alzheimer-Related PS1 Mutations , 2010, Cell.
[13] D. Dickson,et al. IFN-γ Promotes Complement Expression and Attenuates Amyloid Plaque Deposition in Amyloid β Precursor Protein Transgenic Mice , 2010, The Journal of Immunology.
[14] M. Gobbi,et al. Synthetic amyloid-β oligomers impair long-term memory independently of cellular prion protein , 2010, Proceedings of the National Academy of Sciences.
[15] Jin-Moo Lee,et al. Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide , 2009, Proceedings of the National Academy of Sciences.
[16] T. Sata,et al. HIV-1 Accessory Protein Vpu Internalizes Cell-surface BST-2/Tetherin through Transmembrane Interactions Leading to Lysosomes* , 2009, The Journal of Biological Chemistry.
[17] L. Kiemeney,et al. Corrigendum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer , 2009, Nature Genetics.
[18] H. Stenmark. Rab GTPases as coordinators of vesicle traffic , 2009, Nature Reviews Molecular Cell Biology.
[19] Sirkka Goebeler,et al. Apolipoprotein E–dependent accumulation of Alzheimer disease–related lesions begins in middle age , 2009, Annals of neurology.
[20] Guojun Bu,et al. Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy , 2009, Nature Reviews Neuroscience.
[21] D. Holtzman,et al. Microglia Mediate the Clearance of Soluble Aβ through Fluid Phase Macropinocytosis , 2009, The Journal of Neuroscience.
[22] Ralph A. Nixon,et al. Autophagy Induction and Autophagosome Clearance in Neurons: Relationship to Autophagic Pathology in Alzheimer's Disease , 2008, The Journal of Neuroscience.
[23] A. Gräslund,et al. Time-resolved infrared spectroscopy of pH-induced aggregation of the Alzheimer Abeta(1-28) peptide. , 2008, Journal of molecular biology.
[24] Ralph A. Nixon,et al. Autophagy, amyloidogenesis and Alzheimer disease , 2007, Journal of Cell Science.
[25] M. Goedert,et al. A Century of Alzheimer's Disease , 2006, Science.
[26] C. Finch,et al. Synaptic Targeting by Alzheimer's-Related Amyloid β Oligomers , 2004, The Journal of Neuroscience.
[27] J. Buxbaum,et al. Aβ localization in abnormal endosomes: association with earliest Aβ elevations in AD and Down syndrome , 2004, Neurobiology of Aging.
[28] V. Puri,et al. Rab proteins mediate Golgi transport of caveola-internalized glycosphingolipids and correct lipid trafficking in Niemann-Pick C cells. , 2002, The Journal of clinical investigation.
[29] W. K. Cullen,et al. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.
[30] A. Yang,et al. Lysosomal Membrane Damage in Soluble Aβ-Mediated Cell Death in Alzheimer's Disease , 2001, Neurobiology of Disease.
[31] B T Hyman,et al. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. , 2000, The American journal of pathology.
[32] A. Yang,et al. Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Aβ1‐42 pathogenesis , 1998, Journal of neuroscience research.
[33] R. Nixon,et al. Increased Neuronal Endocytosis and Protease Delivery to Early Endosomes in Sporadic Alzheimer’s Disease: Neuropathologic Evidence for a Mechanism of Increased β-Amyloidogenesis , 1997, The Journal of Neuroscience.
[34] K Kontula,et al. Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein. , 1995, The New England journal of medicine.
[35] G. Getz,et al. Purification of Apolipoprotein E Attenuates Isoform-specific Binding to -Amyloid (*) , 1995, The Journal of Biological Chemistry.
[36] G. Getz,et al. Isoform-specific binding of apolipoprotein E to beta-amyloid. , 1994, The Journal of biological chemistry.
[37] A D Roses,et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[38] C. Glabe,et al. Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/beta protein. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[39] D. G. Clark,et al. Common variants at MS 4 A 4 / MS 4 A 6 E , CD 2 AP , CD 33 and EPHA 1 are associated with late-onset Alzheimer ’ s disease , 2011 .
[40] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .
[41] Nick C Fox,et al. Letter abstract - Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's Disease , 2009 .
[42] L. J. Eldik,et al. ApoE and Aβ1–42 interactions , 2007, Journal of Molecular Neuroscience.
[43] R. Nixon,et al. Lysosomal system pathways: genes to neurodegeneration in Alzheimer's disease. , 2006, Journal of Alzheimer's disease : JAD.
[44] D. Selkoe,et al. Natural oligomers of the amyloid-β protein specifically disrupt cognitive function , 2005, Nature Neuroscience.
[45] L. V. Van Eldik,et al. ApoE and Abeta1-42 interactions: effects of isoform and conformation on structure and function. , 2004, Journal of molecular neuroscience : MN.
[46] P. Mathews,et al. The neuronal endosomal-lysosomal system in Alzheimer's disease. , 2001, Journal of Alzheimer's disease : JAD.
[47] Donald,et al. Isoform-specific Binding of Apolipoprotein E to p-Amyloid* , 2001 .
[48] R. Mahley,et al. Apolipoprotein E: far more than a lipid transport protein. , 2000, Annual review of genomics and human genetics.